Archive.fm

Biotech 2050 Podcast

68. Patient-focused Wet AMD, Nancy Lurker, President & CEO, Said Saim, CTO, EyePoint Pharmaceuticals

Nancy Lurker: President & Chief Executive Officer Our President, CEO, and a director since September 2016, Ms Lurker has broad-ranging experience in the pharmaceutical industry and a track record of maximizing the potential of new therapies and successfully implementing innovative US and global drug launches.

Said Saim, PhD: Chief Technology Officer Dr Saim has more than 25 years of product development experience. Dr Saim has published 22 papers in engineering and science journals, holds 18 patents, and earned a PhD in chemical engineering from the University of Kansas.

Broadcast on:
11 Aug 2021